{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06161",
      "entity_text" : "histone deacetylase inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Low-dose AZA maintenance therapy after allo-HSCT has been reported in patients with AML and myelodysplastic syndrome.11, 12 AZA after allo-HSCT can induce a CD8 + T-cell response to tumor antigens, raising the possibility that it may have the potential to augment a graft-versus-leukemia (GVL) response.13 It has been reported that a high expression of ERG is linked with an unfavorable prognosis in a subgroup of leukemic patients with AML and acute T-lymphoblastic leukemia.14 It has also been reported that several accompanying mutation in epigenetic regulators (DNMT3A, ASXL1, BCOR) by targeted NGS approach in AML with FUS-ERG cases.15 ERG positive prostate cancer cells have been reported to induce epigenetic activation of Tudor domain containing protein 1, and histone deacetylase inhibitors induce apoptosis and affect the acetylation status of p53.16, 17 We administered AZA for pediatric AML with FUS-ERG that early relapse occurred after the first CR with allo-HSCT.",
  "reading_complete" : "2020-08-03T17:11:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:08:52Z",
  "trigger" : "induce",
  "evidence" : [ "histone deacetylase inhibitors induce apoptosis" ],
  "pmc_id" : "6878075",
  "score" : 0
}